Manufacturing roundup: FDA clears the way for more monkeypox vaccines to be released; Discovery Life Science nets acquisition
While the monkeypox virus continues to rage across the country, more vaccines are making their way to the US.
According to a report from the AP, thousands more doses of the monkeypox and smallpox vaccine Jynneos, manufactured by Bavarian Nordic, are expected to soon be shipped to the US after the FDA said they had completed an inspection of a Denmark-based manufacturing plant.
More than 1.1 million doses of the vaccine purchased by the US government are currently sitting in Bavarian Nordic’s facility. The company previously said that it needed authorization from an on-site FDA inspection before it could be shipped stateside.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.